Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database

Overview of attention for article published in Frontiers in Pharmacology, May 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 1 news story.

A new report has identified new adverse event (AE) signals which the authors say may be associated with the chronic lymphocytic…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.